JJ
Johnson & Johnson Portfolio holdings
AUM
$334M
This Quarter Return
+10.76%
1 Year Return
+16.18%
3 Year Return
+88.55%
5 Year Return
–
10 Year Return
–
AUM
$427M
AUM Growth
+$427M
(+6.7%)
Cap. Flow
-$2.65M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
94.37%
Holding
21
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Clearside Biomedical
CLSD
|
$105K |
Top Sells
| 1 |
BiomX
PHGE
|
$1.77M |
| 2 |
Aldeyra Therapeutics
ALDX
|
$992K |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protagonist Therapeutics
PTGX
$3.67B
| $110M | 25.79% | 2,449,183 | – | – |
|
|
RAPP
2
Rapport Therapeutics
RAPP
$643M
| $51.2M | 11.97% | 2,498,051 | – | – |
|
3
Legend Biotech
LEGN
$6.41B
| $39.7M | 9.29% | 814,586 | – | – |
|
|
CTNM
4
Contineum Therapeutics
CTNM
$293M
| $37.9M | 8.86% | 1,979,173 | – | – |
|
5
CVRx
CVRX
$205M
| $36.2M | 8.46% | 4,103,430 | – | – |
|
|
NBTX
6
Nanobiotix
NBTX
$429M
| $32.3M | 7.57% | 5,623,816 | – | – |
|
7
Procept Biorobotics
PRCT
$2.23B
| $28.7M | 6.71% | 357,939 | – | – |
|
8
MeiraGTx Holdings
MGTX
$587M
| $27.7M | 6.48% | 6,641,064 | – | – |
|
9
Neumora Therapeutics
NMRA
$280M
| $24.4M | 5.72% | 1,849,445 | – | – |
|
10
Xencor
XNCR
$580M
| $15M | 3.52% | 748,062 | – | – |
|
11
Fate Therapeutics
FATE
$120M
| $11.8M | 2.77% | 3,379,064 | – | – |
|
12
Arrowhead Research
ARWR
$3.05B
| $4.8M | 1.12% | 247,598 | – | – |
|
13
Rallybio
RLYB
$22.4M
| $4.25M | 1% | 3,636,363 | – | – |
|
14
Nano X Imaging
NNOX
$247M
| $966K | 0.23% | 158,852 | – | – |
|
15
Vor Biopharma
VOR
$250M
| $752K | 0.18% | 1,074,658 | – | – |
|
16
Standard BioTools
LAB
$481M
| $602K | 0.14% | 311,967 | – | – |
|
17
Adicet Bio
ACET
$59.9M
| $525K | 0.12% | 364,472 | – | – |
|
|
18
BiomX
PHGE
$14.3M
| $196K | 0.05% | 192,321 -1,730,880 | -90% | -$1.77M |
|
|
19
Clearside Biomedical
CLSD
$28.9M
| $105K | 0.02% | +82,481 | New | +$105K |
|
20
Senseonics Holdings
SENS
$374M
| $19.1K | ﹤0.01% | 54,621 | – | – |
|
|
21
Aldeyra Therapeutics
ALDX
$351M
| – | – | -299,669 | Closed | -$992K |
|